Search - tctmd.com

Displaying 41 - 60 of 324

Sort: Relevancy | Date

News Conference News HRS 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

Michael O'Riordan

May 23, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

FDA Grants MACE Reduction Indication for Semaglutide

Todd Neale

March 08, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

Women Gain More From Exercise Than Men—and Get Away With Less

Michael O'Riordan

February 22, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks

L.A. McKeown

January 24, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

JACC Statement Focuses on PAD Disparities, Gaps in Care

L.A. McKeown

December 04, 2023

News Daily News

New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO

Todd Neale

November 30, 2023

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

Todd Neale

November 20, 2023

News Conference News AHA 2023

Sudden Cardiac Death Declining Among NCAA Athletes

Michael O'Riordan

November 15, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Daily News

Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow

Michael O'Riordan

November 02, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

Advertisement

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

FDA Grants MACE Reduction Indication for Semaglutide

Debating the Role of T-TEER in the Sickest Patients

Women Gain More From Exercise Than Men—and Get Away With Less

February 2024 Dispatch for the CV Team

Short Bouts of Physical Activity May Offset Occupational Sitting CVD Risks

January 2024 Dispatch for the CV Team

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

JACC Statement Focuses on PAD Disparities, Gaps in Care

New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

Sudden Cardiac Death Declining Among NCAA Athletes

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

FDA Grants Tirzepatide a New Indication for Obesity Management

Very High LDL Cholesterol Declines in US Adults, but Progress Is Slow

October 2023 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content